Clinical trial
DILIPO (DILutIonal HyPOnatremia)
NCT00274326 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00274326 |
|---|---|
| Title | DILIPO (DILutIonal HyPOnatremia) |
| Official title | A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients With Dilutional Hyponatremia |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | SR121463B |
| Enrollment | 150 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 10, 2006 |
| Last update posted | Sep 15, 2008 |
| Countries | Argentina, Australia, Belgium, Canada, Chile, Denmark, Greece, Hungary, Israel, Poland, Portugal, Romania and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: